In a move that is expected to prove transformative to the national HIV-prevention effort, the federal government has announced that almost all health insurers must cover the HIV prevention pill, known ...

Gilead Sciences, after striking a similar deal in 2014 to delay generics of its earlier HIV pre-exposure prophylaxis (PrEP) med Truvada, has followed suit on its key next-gen offering Descovy. Monday, ...

Gilead sees the settlement as a way to create a longer runway for new, longer-acting HIV prevention drugs. HIV drug pioneer Gilead Sciences Inc. made sure its leadership spot is well protected into ...

After a run of court victories in a five-year patent dispute with the U.S. government, Gilead Sciences has agreed to settle with the Department of Justice (DOJ) and the Department of Health and Human ...